Pharmacovigilance monitors the lifecycle ... adverse reactions and summarising potential safety concerns in aggregate reports. By incorporating real-world patient feedback alongside structured ...

Cases of secondary tumors have been reported as a possible adverse reaction to the treatment of certain blood cancers with CAR T-cells. A recent analysis of the cases reported to the ...